Highlights and Quick Summary
- Total non-current liabilities for the quarter ending February 28, 2023 was $8.32 Million (a -1.5% decrease compared to previous quarter)
- Year-over-year quarterly Total non-current liabilities decreased by -39.78%
- Annual Total non-current liabilities for 2022 was $10.8 Million (a -71.38% decrease from previous year)
- Annual Total non-current liabilities for 2021 was $37.8 Million (a -52.28% decrease from previous year)
- Annual Total non-current liabilities for 2020 was $79.2 Million (a 82.21% increase from previous year)
Visit stockrow.com/OGI
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Total non-current liabilities of Organigram Holdings Inc.
Most recent Total non-current liabilitiesof OGI including historical data for past 10 years.Interactive Chart of Total non-current liabilities of Organigram Holdings Inc.
Organigram Holdings Inc. Total non-current liabilities for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | $8.32 | – | – | – | – |
| 2022 | $8.45 | $10.82 | $13.82 | $19.47 | $10.82 |
| 2021 | $26.48 | $37.82 | $43.22 | $82.92 | $37.82 |
| 2020 | $58.07 | $79.24 | $58.65 | $9.56 | $79.24 |
| 2019 | $69.36 | $43.49 | $49.19 | $24.64 | $43.49 |
| 2018 | $91.62 | $83.58 | – | – | $83.57 |
Business Profile of Organigram Holdings Inc.
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic